Q32 Bio Inc

Alivexis Inc., based in Cambridge, MA, is a pioneering company specializing in small-molecule targeted therapeutics, focusing on integrating unique biological insights with advanced technology and globally networked operations. The company's mission is to tackle challenging biological targets utilizing advanced structural analysis and supercomputing technologies to accelerate the delivery of therapeutic candidates to patients in need. Composed of an international team of drug discovery scientists, Alivexis boasts extensive experience in pharmaceutical biotechnology and computational research and development. Their commitment to innovation aims to achieve breakthrough discoveries that can significantly impact the future of medicine. Generated from the website

NMD Pharma US Inc, based in Cambridge, MA, specializes in discovering and developing novel therapeutics for neuromuscular diseases. The company focuses on small molecule inhibitors of skeletal muscle-specific ClC1 ion channels, targeting conditions such as myasthenia gravis, spinal muscular atrophy, Charcot-Marie-Tooth disease, and sarcopenia. With a team of global experts, NMD Pharma aims to improve muscle function and enhance the quality of life for patients suffering from neuromuscular disorders. The company has successfully raised significant funding to advance its innovative drug candidates into human clinical trials. Generated from the website